Mymedic Triple Antibiotic Ointment
NDC Package 43473-310-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mymedic Triple Antibiotic (bacitracin zinc, neomycin sulfate, polymyxin b sulfate) ointment is classified as a

administered via topical route. This formulation utilizes a ointment delivery system. Marketed by Nantong Health & Beyond Hygienic Products Inc., this product is identified by NDC 43473-310 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
43473-310-01
Package Description
.9 g in 1 POUCH
Product Code
43473-310
11-Digit Billing Format
43473031001
RxNorm Crosswalk
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
  • RxCUI: 204602 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment

Clinical Specifications

Proprietary Name
Mymedic Triple Antibiotic
Non-Proprietary Name
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate
Substance Name
Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Nantong Health & Beyond Hygienic Products Inc.
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-16-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43473-310-01 identifies a specific commercial package of .9 g in 1 pouch of Mymedic Triple Antibiotic, a human over the counter drug labeled by Nantong Health & Beyond Hygienic Products Inc.. This ointment is formulated for topical use and contains bacitracin zinc; neomycin sulfate; polymyxin b sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nantong Health & Beyond Hygienic Products Inc. on January 16, 2024. The current certification is valid through December 31, 2026.

How is this Nantong Health & Beyond Hygienic Products Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43473031001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43473-310-01
11-Digit CMS (5-4-2)
43473-0310-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.